Table 2.
Number of BZDA prescriptions at baseline and at 1-month, 6-month, and 3-year follow-ups grouped by the BZDA used at baseline and withdrawal status data at 3-year follow-up (non-users, irregular users, and regular BZDA users)
| Zopiclone | Zolpidem | Temazepam | Other BZDA | Total BZDA users | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-users of any BZDA | Irregular | Regular | Irregular | Regular | Irregular | Regular | Irregular | Regular | ||||||||||||
| N | (%) | N | (%) | N | (%) | N | (%) | N | (%) | N | (%) | N | (%) | N | (%) | N | (%) | N | (%) | |
| Baseline (92) | 0 | (0) | 0 | (0) | 52 | (57) | 0 | (0) | 26 | (28) | 0 | (0) | 14 | (15) | 0 | (0) | 0 | (0) | 92 | (100) |
| 1-month (90) | 70 | (78) | 8 | (9) | 1 | (1) | 4 | (4) | 0 | (0) | 6 | (7) | 1 | (1) | 0 | (0) | 0 | (0) | 20 | (22) |
| 6-month (89) | 34 | (38) | 25 | (48) | 6 | (12) | 12 | (46) | 2 | (8) | 7 | (50) | 3 | (21) | 0 | (0) | 0 | (0) | 55 | (62) |
| 3-year (83) | 26 | (31) | 14 | (27) | 15 | (29) | 5 | (19) | 10 | (38) | 6 | (43) | 5 | (36) | 7a | (8) | 1b | (1) | 57 | (69) |
aoxazepam (N = 4), alprazolam (N = 1), diazepam (N = 1) and clonazepam (N = 1)
bchlordiazepoxide with amitriptyline combination preparation (N = 1)